Marcus

MCS · NYSE

$28.64+$0.13 (+0.46%)TodayMarket closed · Oct 20, 4:10 PM ET

Prev close $28.51

MCS analyst rating

BuyConsensus of 4 analysts over the last 12 months. 75% rate it a buy.

Strong buy0
Buy3
Hold1
Underperform0
Sell0

12-month price target · 6 analysts

Average $33.46 (+16.8% upside)

Low: $29.29
Now: $28.64
High: $36.75

Upgrades and downgrades

The latest rating actions, newest first

MCS analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
B. Riley Securities	Jul 31, 2026	Downgrade	Buy → Neutral	$27.00 → $29.00	59%
Benchmark	Jul 31, 2026	Maintains	Buy	$22.00 → $33.00	54%
Wedbush	Jul 31, 2026	Maintains	Outperform	$23.00 → $34.00	56%
B. Riley Securities	Jun 11, 2026	Maintains	Buy	$25.00 → $27.00	59%
Barrington Research	May 4, 2026	Maintains	Outperform	$25.00	58%
Wedbush	Apr 30, 2026	Maintains	Outperform	$22.00 → $23.00	56%
Barrington Research	Mar 2, 2026	Maintains	Outperform	$24.00	58%
Barrington Research	Jan 26, 2026	Maintains	Outperform	$25.00 → $24.00	58%
Barrington Research	Dec 12, 2025	Maintains	Outperform	$25.00	58%
Barrington Research	Nov 3, 2025	Maintains	Outperform	$25.00	58%

The case for and against

Updated Oct 14, 2026

Bull case

Marcus is positioned for fundamental improvement because its theatre business is benefiting from stronger admissions, higher ticket pricing, and a healthier film slate, while hotel demand remains supportive despite a choppier macro backdrop. Q1 revenues of $154.4 million beat estimates, admissions revenue rose 9.8%, EBITDA improved to $2.6 million, and normalized attendance was up over 19% versus the prior Q1 period, showing operating leverage as comparisons normalize. The company’s strong financial position, property ownership, and planned 2026 capex decline to $50-55 million from $83 million in 2025 should bolster free cash flow, support dividends and buybacks, and preserve flexibility for accretive M&A.

Bear case

Marcus is exposed to several fundamental headwinds that weaken its outlook, including a weak macroeconomic environment, fragile consumer confidence, and uncertain box office performance that could pressure its largest revenue driver, the theatres segment. Its reliance on moviegoing also leaves it vulnerable to secular changes in how films are watched, while labor cost and labor availability issues can compress margins across both theatres and Hotels and Resorts. In addition, financial leverage adds balance-sheet risk, making earnings and cash flow more vulnerable if demand softens or operating costs remain elevated.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.